Shanghai Junshi Biosciences Co Ltd Net Asset Quality Index
Shanghai Junshi Biosciences Co Ltd net asset quality index. Shanghai Junshi Biosciences Co Ltd (688180) has a Net Asset Quality Index of 50.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥12.38 Billion minus total liabilities of CN¥6.16 Billion yields net assets of CN¥6.22 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check Shanghai Junshi Biosciences Co Ltd (688180) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Shanghai Junshi Biosciences Co Ltd (2014–2025)
Net asset quality index of Shanghai Junshi Biosciences Co Ltd from 2014 to 2025. This chart shows how Shanghai Junshi Biosciences Co Ltd's Net Asset Quality Index has evolved across 12 annual periods from 2014 to 2025. As of December 2025, the index stands at 50.3%, representing net assets of CN¥6.22 Billion against total assets of CN¥12.38 Billion CNY. See Shanghai Junshi Biosciences Co Ltd (688180) net assets for net asset value and shareholders' equity analysis.
Shanghai Junshi Biosciences Co Ltd Net Asset Quality Index by Year (2014–2025)
Shanghai Junshi Biosciences Co Ltd net asset quality index by year from 2014 to 2025. The table below presents the year-by-year Net Asset Quality Index for Shanghai Junshi Biosciences Co Ltd from 2014 to 2025, covering 12 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Shanghai Junshi Biosciences Co Ltd market cap and net worth.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 50.3% | CN¥6.22 Billion | CN¥12.38 Billion | CN¥6.16 Billion | ▼ -4.8 pp |
| 2024 | 55.1% | CN¥5.95 Billion | CN¥10.80 Billion | CN¥4.85 Billion | ▼ -9.4 pp |
| 2023 | 64.5% | CN¥7.32 Billion | CN¥11.34 Billion | CN¥4.02 Billion | ▼ -13.3 pp |
| 2022 | 77.9% | CN¥9.79 Billion | CN¥12.58 Billion | CN¥2.78 Billion | ▲ +2.5 pp |
| 2021 | 75.4% | CN¥8.33 Billion | CN¥11.05 Billion | CN¥2.72 Billion | ▲ +2.5 pp |
| 2020 | 72.9% | CN¥5.84 Billion | CN¥8.01 Billion | CN¥2.17 Billion | ▲ +5.3 pp |
| 2019 | 67.6% | CN¥2.99 Billion | CN¥4.42 Billion | CN¥1.43 Billion | ▼ -10.4 pp |
| 2018 | 78.0% | CN¥3.32 Billion | CN¥4.26 Billion | CN¥936.18 Million | ▼ -13.8 pp |
| 2017 | 91.8% | CN¥1.12 Billion | CN¥1.22 Billion | CN¥100.38 Million | ▼ -6.3 pp |
| 2016 | 98.0% | CN¥1.13 Billion | CN¥1.15 Billion | CN¥22.41 Million | ▲ +0.3 pp |
| 2015 | 97.7% | CN¥614.22 Million | CN¥628.38 Million | CN¥14.16 Million | ▲ +1.7 pp |
| 2014 | 96.1% | CN¥319.87 Million | CN¥332.94 Million | CN¥13.07 Million | — |